The role of cadherin/catenin complex in malignant melanoma.
暂无分享,去创建一个
A. Batistatou | K. Charalabopoulos | K. Charalabopoulos | A Batistatou | N Bonitsis | S Karantima | K Charalabopoulos | N. Bonitsis | S. Karantima
[1] G. V. van Muijen,et al. Markers of melanocytic tumour progression , 1998, The Journal of pathology.
[2] E. Voura,et al. Cell–cell interactions during transendothelial migration of tumor cells , 1998, Microscopy research and technique.
[3] M. Hendrix,et al. Molecular plasticity of human melanoma cells , 2003, Oncogene.
[4] M. Bar‐eli,et al. Molecular changes in human melanoma metastasis. , 1998, Histology and histopathology.
[5] P. Hersey,et al. Expression of catenins and p120cas in melanocytic nevi and cutaneous melanoma: deficient alpha-catenin expression is associated with melanoma progression. , 1999, Pathology.
[6] J. Nesland,et al. Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma , 2004, Modern Pathology.
[7] B. Gumbiner,et al. Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis , 1996, Cell.
[8] M. N. Epstein,et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. , 1984, Human pathology.
[9] K. A. Meleo. Tumors of the skin and associated structures. , 1997, The Veterinary clinics of North America. Small animal practice.
[10] Yuhei Yamamoto,et al. Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell lines. , 2004, International journal of oncology.
[11] M. Nieto,et al. The snail superfamily of zinc-finger transcription factors , 2002, Nature Reviews Molecular Cell Biology.
[12] Christophe Stove,et al. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. , 2005, Cancer research.
[13] S. Hirohashi,et al. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Bar‐eli,et al. Transcriptional regulation of metastasis-related genes in human melanoma , 2004, Clinical & Experimental Metastasis.
[15] S. Imamura,et al. Identification of novel cadherins expressed in human melanoma cells. , 1997, The Journal of investigative dermatology.
[16] M. Herlyn,et al. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. , 2005, The journal of investigative dermatology. Symposium proceedings.
[17] R. Poulsom,et al. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. , 1993, The American journal of pathology.
[18] D. Elder,et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. , 2000, The American journal of pathology.
[19] M. Hendrix,et al. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). , 2001, Cancer research.
[20] A. Bosserhoff,et al. Loss of E-cadherin Expression in Melanoma Cells Involves Up-regulation of the Transcriptional Repressor Snail* , 2001, The Journal of Biological Chemistry.
[21] S. Hirohashi,et al. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. , 1994, Journal of cell science.
[22] B. Parr,et al. The body language of cells: The intimate connection between cell adhesion and behavior , 1995, Cell.
[23] T. Horikawa,et al. Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation. , 1996, The Journal of investigative dermatology.
[24] L. Akslen,et al. Importance of P-Cadherin, β-Catenin, and Wnt5a/Frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma , 2005, Clinical Cancer Research.
[25] J. Kononen,et al. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. , 1996, American journal of clinical pathology.
[26] K Satyamoorthy,et al. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. , 2001, Cancer research.
[27] M. Herlyn,et al. Dynamics of intercellular communication during melanoma development. , 2000, Molecular medicine today.
[28] G. Christofori,et al. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. , 1999, Trends in biochemical sciences.
[29] A. Amoresano,et al. The structure of the oligosaccharides of N-cadherin from human melanoma cell lines , 2003, Glycoconjugate Journal.
[30] A. Bosserhoff,et al. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma , 2006, Oncogene.
[31] P. McCrea,et al. Catenins as mediators of the cytoplasmic functions of cadherins , 1993, Journal of Cell Science.
[32] Gerhard Christofori,et al. Changing neighbours, changing behaviour: cell adhesion molecule‐mediated signalling during tumour progression , 2003, The EMBO journal.
[33] K. Nakagawa,et al. Soluble E-cadherin fragments increased in circulation of cancer patients. , 1994, British Journal of Cancer.
[34] M. Takeichi,et al. Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.
[35] D. Lev,et al. Cellular Adhesion Pathways and Metastatic Potential of Human Melanoma , 2002, Cancer biology & therapy.
[36] M. Takeichi,et al. Neural crest emigration from the neural tube depends on regulated cadherin expression. , 1998, Development.
[37] Daniel S. Miller,et al. The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer , 2000, Cancer.
[38] W. Birchmeier,et al. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. , 1993, The American journal of pathology.
[39] M. Pasdar,et al. Plasticity of cadherin-catenin expression in the melanocyte lineage. , 2000, Pigment cell research.
[40] E. Dejana,et al. Perspectives Series: Cell Adhesion in Vascular Biology Endothelial Adherens Junctions: Implications in the Control of Vascular Permeability and Angiogenesis , 1996 .
[41] S. Hirohashi,et al. Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma , 2006, Virchows Archiv.
[42] S. Hirohashi,et al. Dysadherin Expression in Head and Neck Squamous Cell Carcinoma: Association With Lymphangiogenesis and Prognostic Significance , 2006, The American journal of surgical pathology.
[43] M. Herlyn,et al. Dynamics of cell interactions and communications during melanoma development. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[44] M. Tronnier,et al. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression , 2004, Journal of cutaneous pathology.
[45] M. Herlyn,et al. Shifts in cadherin profiles between human normal melanocytes and melanomas. , 1996, The journal of investigative dermatology. Symposium proceedings.
[46] E. Danen,et al. E‐cadherin expression in human melanoma , 1996, Melanoma research.
[47] M. Herlyn,et al. Adhesion, migration and communication in melanocytes and melanoma. , 2005, Pigment cell research.
[48] R. Kemler,et al. Molecular organization of the uvomorulin-catenin complex , 1992, The Journal of cell biology.
[49] M. Takeichi,et al. Expression of cadherin cell adhesion molecules during human skin development: morphogenesis of epidermis, hair follicles and eccrine sweat ducts , 1992, Archives of Dermatological Research.
[50] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[51] G. Cowley,et al. CADHERIN EXPRESSION IN MELANOCYTIC NAEVI AND MALIGNANT MELANOMAS , 1996, The Journal of pathology.
[52] Y. Horiguchi,et al. Ultrastructural localization of E-cadherin cell adhesion molecule on the cytoplasmic membrane of keratinocytes in vivo and in vitro. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[53] A. Bosserhoff,et al. A secreted form of P-cadherin is expressed in malignant melanoma. , 2005, Experimental cell research.
[54] K. Syrigos,et al. E‐cadherin/catenin complex in benign and malignant melanocytic lesions , 1998, The Journal of pathology.
[55] M. Mareel,et al. The E-cadherin/catenin complex in invasion and metastasis. , 1996, Current topics in microbiology and immunology.
[56] Paul S. Meltzer,et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[57] L. Liotta,et al. Biology of melanoma invasion and metastasis. , 1987, Pigment cell research.
[58] Judith P. Johnson. Cell Adhesion Molecules in the Development and Progression of Malignant Melanoma , 2004, Cancer and Metastasis Reviews.
[59] W. Birchmeier,et al. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion , 1989, The Journal of cell biology.
[60] P. Dixon,et al. Equine nasal and paranasal sinus tumours: part 2: a contribution of 28 case reports. , 1999, Veterinary journal.
[61] N. Chen,et al. Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. , 2005, Molecular biology of the cell.
[62] W. Birchmeier,et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.
[63] S. Hirohashi,et al. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma , 2005, Cancer.
[64] J. Jankowski,et al. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. , 1999, Molecular pathology : MP.
[65] F. Furukawa,et al. E- and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer. , 1996, Journal of dermatological science.
[66] M. Goldschmidt,et al. A Comparative Review of Melanocytic Neoplasms , 2002, Veterinary pathology.
[67] D. Elder,et al. Human melanoma progression in skin reconstructs : biological significance of bFGF. , 2000, The American journal of pathology.
[68] M. Herlyn,et al. Role of cadherins and matrixins in melanoma , 2001, Current opinion in oncology.
[69] K. Toda,et al. Roles of E‐ and P‐cadherin in the human skin , 1997, Microscopy research and technique.
[70] M. Herlyn,et al. Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. , 2000, Journal of cell science.
[71] S. Hirohashi,et al. Involvement of dysadherin and E-cadherin in the development of testicular tumours , 2005, British Journal of Cancer.
[72] B. Gumbiner,et al. Molecular and functional analysis of cadherin-based adherens junctions. , 1997, Annual review of cell and developmental biology.
[73] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[74] W. Birchmeier,et al. Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. , 1993, Seminars in cancer biology.
[75] M. Bar‐eli. Molecular mechanisms of melanoma metastasis , 1997, Journal of cellular physiology.